Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Anaerobe Systems CCMB-TAL - Cycloserine Cefoxitin Mannitol Broth with Taurocholate and Lysozyme, 10 Tubes/Pkg, Refrigerated requires overnight shipping
SDP

Supplier:  Anaerobe Systems AS8216

Encompass_Preferred

Cycloserine Cefoxitin Mannitol Broth with Taurocholate and Lysozyme (CCMB-TAL) is an enriched, selective, and differential broth media used for the isolation and presumptive identification of C. difficile. This media is prepared, dispensed, and packaged under oxygen-free conditions to prevent the formation of oxidized products prior to use.The nutritive base consists of animal peptones and mannitol. This media is supplemented with cefoxitin and cycloserine at concentrations that inhibit the growth of most normal fecal flora. Cycloserine inhibits gram-negative bacteria, while cefoxitin inhibits gram-positive and gram-negative organisms. Neutral red is added as a pH indicator. The presence of C. difficile will turn the indicator from red/orange to yellow due to the organism utilizing the amino acids and causing an increase in the pH. Sodium Taurocholate and lysozyme are added to help in the germination of spores. Cysteine is added as a reducing agent.

Catalog No. NC9875513


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.